Data as of Sep 02
| +0.16 / +1.22%|
The 6 analysts offering 12-month price forecasts for NxStage Medical Inc have a median target of 18.00, with a high estimate of 20.00 and a low estimate of 12.00. The median estimate represents a +35.54% increase from the last price of 13.28.
The current consensus among 8 polled investment analysts is to Buy stock in NxStage Medical Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.